Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 49.00
+0.50 (1.03%)
Aug 22, 2025, 4:35 PM GMT+1
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 190.45 million as of August 22, 2025. Its market cap has decreased by -19.09% in one year.
Market Cap
190.45M
Enterprise Value
201.80M
Revenue
113.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
49.00
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 190.45M, an increase of 408.42%. That is a compound annual growth rate of 8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 190.45M | 4.10% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | 284.34M | 854.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.83B |
| GSK plc | 60.14B |
| Haleon | 32.68B |
| Smith & Nephew | 12.07B |
| ConvaTec Group | 4.96B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.04B |
| Oxford Nanopore Technologies | 2.03B |